Please Note: THIS FORUM IS PATIENT MODERATED AND IS NOT CONNECTED TO ANY CLINIC OR DOCTOR. IF YOU WISH TO CONTACT A CERTAIN DOCTOR OR CLINIC, PLEASE LOOK IN THE ASK THE DOCTOR SECTION FOR DOCTOR OR CLINIC PHONE NUMBERS AND EMAIL ADDRESSES.

                        Home || Contact Us || Help Registering and Participating || Disclaimer


 Buy 1 Get 1 Free at Puritan's Pride

LivLong – The Ultimate Anti-aging Product

SeaChange Offers Life Extension Products

 

Barbara and Jeannine's Book

Bea Luis Memorial

 


Results 1 to 3 of 3

Thread: Lung disease patients ‘devastated’ at refusal to fund breakthrough drug

  1. #1
    Join Date
    May 2007
    Posts
    12,126
    Blog Entries
    5

    Default Lung disease patients ‘devastated’ at refusal to fund breakthrough drug

    Wednesday, August 09, 2017

    http://www.irishexaminer.com/ireland...ug-456625.html

    By Caroline O'Doherty
    Senior Reporter
    Patients with severe lung disease who have been receiving a life-changing drug have pleaded for help as supply of the medication is to be cut off within weeks.

    Twenty-one patients have been getting Respreeza from its manufacturers on compassionate grounds — some for as long as 10 years — after they participated in clinical trials of it before it was formally approved for use.

    However, health chiefs here failed to agree a price for the drug with the US manufacturer, CSL Behring, and the company is to stop providing it for free from the end of this month.

    Johnny Hannan, from Mallow, Co Cork, who has the Alpha-1 condition that Respreeza keeps in check, is adamant he would not be alive today without it.

    “I started a trial of Respreeza nearly 12 years ago and I’m here today because of it,” he said. “None of us know what the effect will be when we come off it. Will we deteriorate slowly or will we go down hill rapidly? We just don’t know. It’s like waiting on death row.”

    Mr Hannan and the other patients have the inherited condition Alpha-1 which usually results in emphysema, leaving people with severe breathing difficulties and very vulnerable to serious chest infections.

    Respreeza keeps the condition in check and is being prescribed by health authorities in 12 other EU countries. The HSE and Department of Health declared the asking price — €84,000 per patient per year — too high after a study last year.

    CSL Behring was given time to make representations in response but the HSE said yesterday it had considered CSL’s submissions and reached the conclusion that the drug was not sufficiently effective to warrant the expense.

    In a statement, it said: “We are very much aware that this decision is upsetting to the Alpha One Foundation and patients who are affected by this condition. It will also be a disappointment to their families and the treating clinicians who support affected patients.

    Mary Coffey at the HSE headquarters amongst patients Alpha-1 (genetic emphysema), their families, friends, and supporters.
    “We have to consider our wider obligations to the 4.7m population we serve and need to maintain a full range of health services within the finite resources at our disposal.”

    Mr Hannan said patients deserved better.

    “It’s been torture for the last year, getting the drug month to month and not knowing what happens next,” he said. “We are absolutely devastated that, after all we’ve been through, they’re saying no more. We feel let down by the HSE and by the country as a whole.”

    Geraldine Kelly, CEO of the Alpha One Foundation, said the group would not give up.

    “Greece, which has no money, provides this drug to its patients,” she said. “Spain and Portugal too, despite their financial problems. We want the HSE to explore an EU-wide deal with CSL. We’ve only a small number of patients here but the numbers combined across Europe would surely bring the price down.”

    The HSE said it would be notifying CSL Behring of its decision. The company had not received notification at time of publication but said it was “committed to exploring all possibilities to get this important treatment reimbursed for patients”.

    © Irish Examiner Ltd. All rights reserved
    First treatment in 2007. Pioneering ever since.

    Barbara

  2. #2
    Join Date
    Feb 2015
    Location
    USA
    Posts
    27
    Blog Entries
    4

    Default

    https://www.bloomberg.com/graphics/2015-drug-prices/

    Drug companies screw americans over so they can sell cheaper in other countries.
    They make most of their profits in the USA...

  3. #3
    Join Date
    May 2007
    Posts
    12,126
    Blog Entries
    5

    Default

    Indeed they do!
    First treatment in 2007. Pioneering ever since.

    Barbara

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  

Copyright 2007 - 2011 Stem Cell Pioneers